Theralase Technologies Inc. is facing a tough time in the market, with shares dropping significantly.
In today's trading session, Theralase Technologies Inc. (TLT.V) saw its stock price fall by 1.85%. This decline highlights the ongoing challenges the company faces as it navigates its financial situation.
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
Theralase Technologies Inc.
TLT.V
TLT.V
Theralase Technologies Inc.
WealthAwesomeMarket cap
$84.27M
52W high
$0.41
52W low
$0.15
1W change
+0.00%
Beta
0.59
Analyst Price Targets
Based on analyst covering TLT
Wall Street analysts forecast TLT stock price to rise 159.3% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.70
+159.3% Upside
Current Price
C$0.27
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TLT's historical volatility
30-Day Vol
50.8%
Annualized
90-Day Vol
94.4%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.32
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.29 | C$0.24 – C$0.34 |
| 60 trading days | C$0.30 | C$0.24 – C$0.39 |
| 90 trading days | C$0.32 | C$0.24 – C$0.44 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should keep an eye on Theralase's performance and consider the impact of its recent financial activities and market sentiment.
Theralase's stock price declines to CA$0.27
With a market cap of CA$79.83 million, the company's valuation is under scrutiny as it deals with a challenging trading environment.
Bull case
Theralase has shown growth potential in the past, reporting a 45% increase in revenue during its last earnings call. This suggests there may still be a path to recovery.
Bear case
The recent drop in stock price raises concerns among investors about Theralase's ability to maintain its momentum, especially since there hasn’t been any recent news to boost confidence.
Market Reaction to Theralase's Performance
Advertisement
Today, Theralase Technologies Inc. closed down by 1.85% at CA$0.27. This decline comes amid a lack of new developments that could reassure investors. While the company's recent financial statements showed a revenue increase, the absence of fresh news may have contributed to the stock's downward trend.
Understanding Investor Sentiment
The drop in Theralase's stock price reflects a cautious sentiment among investors. With a market cap of CA$79.83 million, stakeholders are likely weighing the company's growth potential against its current challenges. Investors should watch for upcoming announcements or financial reports to see if this trend continues.
Future Outlook for Theralase Technologies
Despite today's decline, Theralase Technologies has shown promise in previous quarters, including a significant revenue increase. Investors may want to consider the company's long-term potential, especially if it can build on its recent achievements and restore investor confidence.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
